Symbiotec Genellschaft zur Erforshung auf dem Geibeit der Biotechnologie; MBH
发明人:
Michael Zeppezauer,Reiner Class
申请号:
US14588836
公开号:
US20150119331A1
申请日:
2015.01.02
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The invention relates to the use of at least one human recombinant histone, especially at least one histone H1 subtype, and/or a therapeutic histone fraction as a basis for the treatment of thrombocytopenia.